Contracts › 75A50124C00058
75A50124C00058: MACH32- Development of Intramuscular Tranexamic Acid Formulation
Awarded to Mach32 Inc by Office of Assistant Secretary for Preparedness and Response.
$750Kobligated
$750Kpotential value
30 November 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50124C00058 |
|---|---|
| Awardee | Mach32 Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN13 Health R&D Services; Health Care Services; Experimental Development |
| Offers received | 1 |
| Period of performance | 27 September 2024 to 30 November 2026 |
| Potential end | 30 November 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record